Solid Tumors and Surgical Oncology.

Abstract

DOI: https://doi.org/10.4037/aacnacc2021712 O component of the armamentarium for the management, conquest, control, or palliation of solid tumors is surgical intervention. Surgical oncologic intervention may be stand-alone, neoadjuvant treatment such as chemotherapy before surgery to shrink tumor size and minimize surgical time and tumor burden, adjuvant therapy such as chemotherapy administered after surgical intervention, or a combination of these. Clinicians consider a number of factors when deciding if a patient is a candidate for surgical oncology intervention, including tumor-specific factors (eg, size, location, stage and grade of the tumor) and patient-specific factors (eg, age, comorbidities).1 As with other management strategies for cancer, surgical intervention is evolving. On the basis of degree of complexity, there are complications and implications for nursing practice. Although the specialty of surgical oncology is multifaceted, the focus of this symposium is on specific nursing practice implications when surgical intervention is an aspect of the management of cancer. In their article, Brophy and colleagues describe multimodal, evidence-based perioperative programs designed to improve a surgical oncology patient’s functional recovery. Enhanced recovery programs promote standardized, multidisciplinary care throughout the perioperative course to improve patient outcomes, rather than focusing on surgical technique. Weber and Kaplow discuss a variety of complex surgical interventions for solid tumors that can lead to extended intraoperative and anesthesia times. Nutrition, infection, postoperative mechanical ventilation, and pneumonia are some of the issues that intensive care unit (ICU) nurses may encounter when caring for this patient population. Brydges and Brydges describe select cancer-related complications and interventions including tumor lysis syndrome, cytoreductive hyperthermic intraperitoneal chemotherapy, increased intracranial pressure, and vena cava thrombus and the associated nursing implications. Gregory and colleagues address the array of innovative therapies that have entered the oncology realm and nursing considerations pertaining to these treatment approaches for solid tumors. Nurses are expected to administer and ultimately manage the resulting toxicities and side effects of these therapies. Solid Tumors and Surgical Oncology